You are here

GLYCOSCIENTIFIC, L.L.C.

Company Information
Address
111 RIVERBEND RD
ATHENS, GA 30602-1514
United States


http://www.glycoscientific.com/

Information

UEI: EUVNNWGFCA87

# of Employees: 5


Ownership Information

HUBZone Owned: Yes

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Recognition of O-GlcNAc Modified Proteins Using Site-Specific Antibodies

    Amount: $275,767.00

    Pulmonary arterial hypertension (PAH) is a progressive disorder characterized by high blood pressure (hypertension) in the arteries of the lungs (pulmonary artery) for no apparent reason. PAH is a dis ...

    SBIRPhase I2023Department of Health and Human Services National Institutes of Health
  2. Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig

    Amount: $600,000.00

    GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in th ...

    SBIRPhase I2023Department of Health and Human Services National Institutes of Health
  3. Development of Isotopically Labeled Glycoproteins for use as Internal Standards

    Amount: $697,095.00

    Project Summary/Abstract The ability to accurately quantitate the glycan chains attached to glycoproteins has wide-ranging implications. Numerous studies over the past 40 years have demonstrated that ...

    STTRPhase II2020Department of Health and Human Services National Institutes of Health
  4. Isotopically Labeled Heparan Sulfate Glycosaminoglycan Disaccharides for use as Internal Standards

    Amount: $252,114.00

    PROJECT SUMMARY/ABSTRACTSulfated glycosaminoglycan (GAG) carbohydrates represent one of the more structurally diverse groups of biomolecules, and a comprehensive understanding of their biological stru ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
  5. Creating Antibodies to Enable the Study of Mycobacterium Tuberculosis Infections in Guinea Pigs

    Amount: $653,191.00

    Tuberculosis is a persistent infectious disease that threatens the health of people and numerous mammalian species throughout the worldMonitoring of Mycobacterium tuberculosisMtbinfections in animal m ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  6. Development of Site-specific Arg-GlcNAc Antibodies

    Amount: $298,483.00

    Human pathogenic gram-negative bacteria, such as Escherichia coli (E. Coli) and Salmonella enterica cause millions of deaths, thousands of fatalities and billions of dollars in medical expenses and lo ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  7. Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research

    Amount: $1,110,831.00

    Project SummaryO glycosylation of nuclear and cytoplasmic proteins by a singleN acetyl D glucosamine moietyOGlcNAcis a common post translational modification that is highly dynamic and fluctuates in r ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  8. Generation of antibodies to monitor Notch O-fucosylation in vivo

    Amount: $242,306.00

    Project Summary Notch is a cell surface protein that has diverse roles in human biology at all stages of life Notch is modified by a number of sugar structures including a number that are termed O ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  9. Development of Isotopically Labeled Glycoproteins for use as Internal Standards

    Amount: $270,251.00

    DESCRIPTION provided by applicant The ability to accurately quantitate the glycan chains attached to glycoproteins has wide ranging implications Numerous studies over the past years have demons ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  10. Antibodies to O-GlcNAc modified histones for chromatin biology and epigenetic res

    Amount: $349,180.00

    DESCRIPTION (provided by applicant): O-glycosylation of nuclear and cytoplasmic proteins by a single ?-N-acetyl-D-glucosamine moiety (O-GlcNAc) is a common post-translational modification that is hig ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government